GDC-0570
GDC-0570 is a novel, potent, selective, orally active pan-PIM inhibitor. GDC-0570 demonstrates synergistic antitumor efficacy when combined with Sotorasib (HY-114277) in acquired KRASis-resistant NSCLC[1].
Product Specifications
CAS Number
[1586041-58-8]
Product Name Alternative
NB004
UNSPSC
12352005
Target
Pim
Related Pathways
JAK/STAT Signaling
Field of Research
Cancer
Smiles
O=C(C1=CSC(C2=C(C=CC=C2F)F)=N1)NC3=C([C@@H]4CC[C@H]([C@@H](CO4)F)N)N(N=C3)C
Molecular Formula
C20H20F3N5O2S
Molecular Weight
451.47
References & Citations
[1]Fu S, et al. Abstract CT116: Preclinical antitumor activity and first-in-human phase I study of NB004/GDC-0570, a novel pan-PIM kinase inhibitor, in patients with advanced solid tumors[J]. Cancer Research, 2024, 84 (7_Supplement) : CT116-CT116.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
302271-APC 200 µL
APBB3 (Amyloid beta A4 precursor Protein-Binding Family B Member 3, Protein Fe65-like 2, Fe65L2, APBB3, FE65L2) (APC) discontinued
Ask
View Details MBS1048474-01 0.02 mg (E-Coli)
Recombinant Anoxybacillus flavithermus Probable transcriptional regulatory protein Aflv_0709 (Aflv_0709)
Ask
View Details 
MBS1048474-02 0.1 mg (E-Coli)
Recombinant Anoxybacillus flavithermus Probable transcriptional regulatory protein Aflv_0709 (Aflv_0709)
Ask
View Details MBS1048474-03 0.02 mg (Yeast)
Recombinant Anoxybacillus flavithermus Probable transcriptional regulatory protein Aflv_0709 (Aflv_0709)
Ask
View Details 
MBS1048474-04 0.1 mg (Yeast)
Recombinant Anoxybacillus flavithermus Probable transcriptional regulatory protein Aflv_0709 (Aflv_0709)
Ask
View Details